IPSC Century Therapeutics Inc

Price (delayed)

$2.21

Market cap

$398.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$389.12M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2
Highlights
The equity has surged by 67% since the previous quarter and by 10% year-on-year
The quick ratio has surged by 71% since the previous quarter but it has declined by 13% year-on-year
The debt has grown by 9% since the previous quarter but it has declined by 8% year-on-year
Century Therapeutics's gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Key stats

What are the main financial stats of IPSC

IPSC stock price

How has the Century Therapeutics stock price performed over time
Intraday
6.76%
1 week
-7.34%
1 month
-3.49%
1 year
289.77%
YTD
122.16%
QTD
-2.21%

Financial performance

How have Century Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$115.12M
Net income
-$107.78M
Gross margin
N/A
Net margin
N/A
Century Therapeutics's gross profit has plunged by 100% from the previous quarter and by 100% YoY
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Price vs fundamentals

How does IPSC's price correlate with its fundamentals

Growth

What is Century Therapeutics's growth rate over time

Valuation

What is Century Therapeutics stock price valuation
P/E
N/A
P/B
1.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IPSC's price to book (P/B) is 135% higher than its last 4 quarters average of 0.6 and 18% higher than its 5-year quarterly average of 1.2
The equity has surged by 67% since the previous quarter and by 10% year-on-year
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Century Therapeutics business performance

Dividends

What is IPSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IPSC.

Financial health

How did Century Therapeutics financials performed over time
The current ratio has soared by 72% from the previous quarter but it has contracted by 12% YoY
The quick ratio has surged by 71% since the previous quarter but it has declined by 13% year-on-year
The debt is 83% smaller than the equity
The equity has surged by 67% since the previous quarter and by 10% year-on-year
IPSC's debt to equity is down by 32% since the previous quarter and by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.